-
Mashup Score: 2Unite for Hope: Maryland Half Marathon & 5K calls on runners and walkers to fuel cancer research - 2 month(s) ago
Dana Deighton, a former patient at the Greenebaum Comprehensive Cancer Center, and Tiffani Tyer, Nurse practitioner in Radiation Oncology, join us to share important information on the marathon and how the 5k is more than a race and affects the lives of many.
Source: www.cbsnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 0The history of Black History Month makes us question this - 4 month(s) ago
What is the work we’re willing to do?
Source: apple.newsCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2LUTH partners US varsity on disease treatment - 11 month(s) ago
The Lagos University Teaching Hospital has partnered the University of Maryland School of Medicine, Baltimore, United States, on capacity building, research and treatment of non-communicable diseases.
Source: punchng.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 27UM, AstraZeneca partner to boost lung cancer screenings - 1 year(s) ago
Big institutions in Maryland are joining forces to enhance community-based lung cancer screenings for those at high risk.
Source: www.wbaltv.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23
Karen Warmkessel 410-328-8919 or (410) 404-1532 (cell) [email protected] Deborah Kotz 410-706-4255 or 617-898-7955 (cell) [email protected]
Source: www.medschool.umaryland.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Sign the Petition - 2 year(s) ago
Eliminate ABIMs MOC requirement
Source: www.change.orgCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0The world’s platform for change - 2 year(s) ago
Change.org is the world’s largest petition platform, using technology to empower more than 200 million users to create the change they want to see.
Source: Change.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Tarlatamab, a first-in-class DLL3-targeted bispecific T cell engager, in recurrent small-cell lung cancer: an open-label, phase 1 study - PubMed - 2 year(s) ago
In patients with heavily pretreated SCLC, tarlatamab demonstrated manageable safety with encouraging response durability. Further evaluation of this promising molecule is ongoing.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Hydroxyurea and EPO in Sickle Cell Disease – Full Text View.
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
Lagos university hospital, Nigeria for the site initiation visit for the ACHiEvE-SCD study for #sickle, a collaboration between @PittVMI and @LUTHofficial led by @JuliaXuMD, @TitiAdeyem0 @UPMCnews @chansteve73 @UPMCHillmanCC @EnricoNovelli @BIOVentures https://t.co/JZSPPszr5r https://t.co/OKoxp8c9Wo
-
-
Mashup Score: 0
#KeepDrJosieRolling I started this campaign for Josie, my wife of 22 … Stasa Tadic needs your support for Keep Dr Josie Rolling: Wheelchair Van, Bathroom
Source: gofundme.comCategories: Hem/Oncs, Latest HeadlinesTweet
Great interview by our patient and teammate getting ready for the Half marathon and 5K run to benefit @UMGCCC https://t.co/9rjX2VclqO